NewAmsterdam Pharma Company N.V. (NAMS) Stock Price History
Historical prices from 2021 to 2026
Loading 10-year price history...
NAMS Historical Performance
Short-Term Returns
NAMS Stock Price Trajectory (2021–2026)
As of May 17, 2026, NewAmsterdam Pharma Company N.V. (NAMS) trades at $35.44, representing a +89.5% return over the past year. The stock has delivered a +260.9% total return over five years (+29.3% CAGR), reflecting significant long-term value creation.
The stock reached its all-time high of $42.21 on May 11, 2026. From this peak, NAMS has corrected -16.0%, currently trading 10% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers ESPR (+301.4% 1Y), MDGL (+79.5% 1Y), and LNTH (+17.7% 1Y), NAMS has underperformed the peer group average. Compare NAMS vs ESPR →
NAMS Historical Price Data (2026–2026)
Showing 30 of 1,324 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-15 | 36.63 | 36.63 | 35.08 | 35.44 | 1.10M | -3.90% |
| 2026-05-14 | 37.62 | 37.80 | 36.45 | 36.88 | 952K | -2.30% |
| 2026-05-13 | 38.36 | 38.87 | 36.96 | 37.75 | 1.74M | -2.93% |
| 2026-05-12 | 39.63 | 39.74 | 38.32 | 38.89 | 2.14M | -1.77% |
| 2026-05-11 | 37.62 | 42.20 | 37.62 | 39.59 | 2.74M | +2.22% |
| 2026-05-08 | 34.85 | 41.17 | 34.85 | 38.73 | 4.73M | +11.13% |
| 2026-05-07 | 33.02 | 35.05 | 31.12 | 34.85 | 2.50M | +12.46% |
| 2026-05-06 | 30.22 | 31.06 | 29.86 | 30.99 | 1.04M | +3.68% |
| 2026-05-05 | 29.95 | 31.00 | 29.10 | 29.89 | 880K | +0.10% |
| 2026-05-04 | 28.23 | 29.90 | 28.09 | 29.86 | 1.34M | +5.03% |
| 2026-05-01 | 28.74 | 29.11 | 28.03 | 28.43 | 1.38M | -0.46% |
| 2026-04-30 | 29.19 | 29.31 | 28.30 | 28.56 | 571K | +0.46% |
| 2026-04-29 | 28.40 | 28.71 | 27.93 | 28.43 | 610K | -1.01% |
| 2026-04-28 | 30.45 | 30.96 | 27.85 | 28.72 | 1.43M | -5.68% |
| 2026-04-27 | 30.45 | 31.32 | 29.84 | 30.45 | 1.24M | +2.46% |
| 2026-04-24 | 31.52 | 31.75 | 29.53 | 29.72 | 933K | -5.53% |
| 2026-04-23 | 32.05 | 33.27 | 31.30 | 31.46 | 509K | -1.50% |
| 2026-04-22 | 32.90 | 33.00 | 31.59 | 31.94 | 1.64M | -1.66% |
| 2026-04-21 | 33.70 | 33.70 | 32.29 | 32.48 | 927K | -3.91% |
| 2026-04-20 | 34.66 | 35.28 | 33.69 | 33.80 | 430K | -2.54% |
| 2026-04-17 | 34.19 | 34.95 | 33.57 | 34.68 | 637K | +4.46% |
| 2026-04-16 | 33.79 | 34.31 | 32.86 | 33.20 | 785K | -2.38% |
| 2026-04-15 | 34.59 | 34.75 | 33.26 | 34.01 | 735K | -1.25% |
| 2026-04-14 | 36.58 | 36.73 | 34.32 | 34.44 | 1.60M | -4.99% |
| 2026-04-13 | 34.65 | 36.29 | 34.22 | 36.25 | 712K | +4.29% |
| 2026-04-10 | 34.92 | 35.44 | 34.54 | 34.76 | 540K | -0.88% |
| 2026-04-09 | 33.74 | 35.35 | 33.74 | 35.07 | 415K | +3.12% |
| 2026-04-08 | 34.05 | 34.22 | 33.30 | 34.01 | 945K | +0.29% |
| 2026-04-07 | 33.77 | 34.25 | 32.88 | 33.91 | 1.03M | -0.62% |
| 2026-04-06 | 32.51 | 34.39 | 32.47 | 34.12 | 1.13M | +3.43% |
See NAMS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NAMS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NAMS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNAMS — Frequently Asked Questions
Quick answers to the most common questions about buying NAMS stock.
How has NAMS stock performed recently?
NAMS returned +89.5% over the past year, beating its 5-year annualized CAGR of +29.3%. The stock trades above its 200-day moving average, confirming the uptrend.
What is NAMS's all-time high price?
NewAmsterdam Pharma Company N.V. reached $42.20 on 2026-05-11. The 52-week high is $42.20. Current 1-year return of +89.5% places the stock closer to historical peaks.
Where can I download NAMS historical price data?
This page provides NAMS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.